New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS), and its animal model experimental autoimmune encephalomyelitis, are neuroinflammatory diseases driven by autoreactive pathogenic TH cells that elicit demyelination and axonal damage. How TH cells acquire pathogenicity and communicate with myeloid cells and cells of the CNS remain unclear. IL-1β is recognized to play an important role in experimental autoimmune encephalomyelitis (EAE) and perhaps MS. Clinical EAE is significantly attenuated in IL-1R–deficient and IL-1β–deficient mice, and IL-1β is found in the blood, cerebrospinal fluid, and CNS lesions of MS patients. In this article, we focus on new reports that elucidate the cellular sources of IL-1β and its actions during EAE, in both lymphoid tissues and within the CNS. Several immune cell types serve as critical producers of IL-1β during EAE, with this cytokine inducing response in both hematopoietic and nonhematopoietic cells. These findings from the EAE model should inspire efforts toward investigating the therapeutic potential of IL-1 blockade in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Non-canonical inflammasome activation targets caspase-11
Kayagaki, N., Warming, S., Lamkanfi, M., Walle, L. V., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S., et al. (2011) · Nature · doi:10.1038/nature10558 · Cited by 2,530
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191 · cited 8×
“development (80, 81), the earlier studies did not provide a”
BackgroundResultInfluentialFate mapping of IL-17-producing T cells in inflammatory responses
Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., et al. (2011) · Nature Immunology · doi:10.1038/ni.1993 · Cited by 1,176
El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071 · cited 8×
“development (80, 81), the earlier studies did not provide a”
BackgroundResultInfluentialInterleukin 1α and the inflammatory process
Di Paolo, N. C., & Shayakhmetov, D. M. (2016) · Nature Immunology · doi:10.1038/ni.3503 · Cited by 568
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., Pelczar, P., Clausen, B. E., Jung, S., Greter, M., & Becher, B. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.010 · Cited by 484 · cited 2×
“We and others also found IL-1b–producing myeloid cells in peripheral lymphoid organs at days 5–8 after EAE induction (31, 32, 36, 62).”
BackgroundGris, D., Ye, Z., Iocca, H. A., Wen, H., Craven, R. R., Gris, P., Huang, M., Schneider, M., Miller, S. D., & Ting, J. P.-Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904145 · Cited by 429
Inflammasome-independent regulation of IL-1-family cytokines
Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W. M., Dinarello, C. A., & Joosten, L. A. B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112306 · Cited by 326
Research works printed but not linked: 100
- Malik, 2016, The emerging roles of gamma-delta T cells in tissue inflammation in experimental autoimmune encephalomyelitis, Front. Immunol., 7, 14, 10.3389/fimmu.2016.00014 · DOI · Paper page
- Salou, 2015, Involvement of CD8(+) T cells in multiple sclerosis, Front. Immunol., 6, 604, 10.3389/fimmu.2015.00604 · DOI · Paper page
- Sinha, 2015, CD8(+) T-cells as immune regulators of multiple sclerosis, Front. Immunol., 6, 619, 10.3389/fimmu.2015.00619 · DOI · Paper page
- Hohlfeld, 2016, The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research, Lancet Neurol., 15, 317, 10.1016/S1474-4422(15)00313-0 · DOI · Paper page
- Claes, 2015, B cells are multifunctional players in multiple sclerosis pathogenesis: insights from therapeutic interventions, Front. Immunol., 6, 642, 10.3389/fimmu.2015.00642 · DOI · Paper page
- Stromnes, 2006, Active induction of experimental allergic encephalomyelitis, Nat. Protoc., 1, 1810, 10.1038/nprot.2006.285 · DOI · Paper page
- Levine, 1973, Experimental allergic encephalomyelitis in inbred and outbred mice, J. Immunol., 110, 139, 10.4049/jimmunol.110.1.139 · DOI · Paper page
- Bettelli, 1998, IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice, J. Immunol., 161, 3299, 10.4049/jimmunol.161.7.3299 · DOI · Paper page
- Codarri, 2013, Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease, Trends Immunol., 34, 114, 10.1016/j.it.2012.09.007 · DOI
- Croxford, 2015, GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage, Trends Immunol., 36, 651, 10.1016/j.it.2015.08.004 · DOI
- Becher, 2016, GM-CSF: from growth factor to central mediator of tissue inflammation, Immunity, 45, 963, 10.1016/j.immuni.2016.10.026 · DOI · Paper page
- Cerretti, 1992, Molecular cloning of the interleukin-1 beta converting enzyme, Science, 256, 97, 10.1126/science.1373520 · DOI · Paper page
- Thornberry, 1992, A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes, Nature, 356, 768, 10.1038/356768a0 · DOI · Paper page
- Piccioli, 2013, The secretion of IL-1β and options for release, Semin. Immunol., 25, 425, 10.1016/j.smim.2013.10.007 · DOI
- Boraschi, 2013, The interleukin-1 receptor family, Semin. Immunol., 25, 394, 10.1016/j.smim.2013.10.023 · DOI · Paper page
- Symons, 1987, Cerebrospinal fluid interleukin 1 like activity during chronic relapsing experimental allergic encephalomyelitis, Clin. Exp. Immunol., 68, 648
- Mannie, 1987, Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats, J. Immunol., 138, 4229, 10.4049/jimmunol.138.12.4229 · doi:10.4049/jimmunol.138.12.4229
- Baker, 1991, Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis, Cell. Immunol., 134, 505, 10.1016/0008-8749(91)90321-2 · DOI
- Kennedy, 1992, Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery, J. Immunol., 149, 2496, 10.4049/jimmunol.149.7.2496 · DOI · Paper page
- Bauer, 1993, Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level, J. Neuroimmunol., 48, 13, 10.1016/0165-5728(93)90053-2 · DOI
- Jacobs, 1991, Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor, J. Immunol., 146, 2983, 10.4049/jimmunol.146.9.2983 · DOI · Paper page
- Martin, 1995, Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats, J. Neuroimmunol., 61, 241, 10.1016/0165-5728(95)00108-E · DOI
- Badovinac, 1998, Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells, J. Neuroimmunol., 85, 87, 10.1016/S0165-5728(98)00020-4 · DOI
- Wiemann, 1998, Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist, Exp. Neurol., 149, 455, 10.1006/exnr.1997.6723 · DOI
- Schiffenbauer, 2000, The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor, Clin. Immunol., 95, 117, 10.1006/clim.2000.4851 · DOI
- Sutton, 2006, A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis, J. Exp. Med., 203, 1685, 10.1084/jem.20060285 · DOI · Paper page
- Lukens, 2012, Inflammasome-derived IL-1β regulates the production of GM-CSF by CD4(+) T cells and γδ T cells, J. Immunol., 188, 3107, 10.4049/jimmunol.1103308 · DOI · Paper page
- Lin, 2016, IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation, J. Exp. Med., 213, 251, 10.1084/jem.20150568 · DOI · Paper page
- Lévesque, 2016, Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice, J. Exp. Med., 213, 929, 10.1084/jem.20151437 · DOI · Paper page
- Mufazalov, 2017, IL-1 signaling is critical for expansion but not generation of autoreactive GM-CSF+ Th17 cells, EMBO J., 36, 102, 10.15252/embj.201694615 · DOI
- Matsuki, 2006, Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis, Int. Immunol., 18, 399, 10.1093/intimm/dxh379 · DOI · Paper page
- Inoue, 2012, NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis, Proc. Natl. Acad. Sci. USA, 109, 10480, 10.1073/pnas.1201836109 · DOI · Paper page
- Inoue, 2012, Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome, Sci. Signal., 5, ra38, 10.1126/scisignal.2002767 · DOI · Paper page
- Inoue, 2016, An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage, Nat. Neurosci., 19, 1599, 10.1038/nn.4421 · DOI · Paper page
- Shaw, 2010, Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis, J. Immunol., 184, 4610, 10.4049/jimmunol.1000217 · DOI · Paper page
- Furlan, 1999, Caspase-1 regulates the inflammatory process leading to autoimmune demyelination, J. Immunol., 163, 2403, 10.4049/jimmunol.163.5.2403 · DOI · Paper page
- Hisahara, 2001, Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination, J. Exp. Med., 193, 111, 10.1084/jem.193.1.111 · DOI
- Shao, 2014, Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome, CNS Neurosci. Ther., 20, 1021, 10.1111/cns.12349 · DOI · Paper page
- Lalor, 2011, Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity, J. Immunol., 186, 5738, 10.4049/jimmunol.1003597 · DOI · Paper page
- Hauser, 1990, Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6, Neurology, 40, 1735, 10.1212/WNL.40.11.1735 · DOI · Paper page
- Dujmovic, 2009, The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: the elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy, J. Neuroimmunol., 207, 101, 10.1016/j.jneuroim.2008.11.004 · DOI
- Wucherpfennig, 1992, T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions, J. Exp. Med., 175, 993, 10.1084/jem.175.4.993 · DOI · Paper page
- Woodroofe, 1993, Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization, Cytokine, 5, 583, 10.1016/S1043-4666(05)80008-0 · DOI · Paper page
- Cannella, 1995, The adhesion molecule and cytokine profile of multiple sclerosis lesions, Ann. Neurol., 37, 424, 10.1002/ana.410370404 · DOI · Paper page
- Argaw, 2006, IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program, J. Immunol., 177, 5574, 10.4049/jimmunol.177.8.5574 · DOI · Paper page
- Burm, 2016, Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself, J. Neuroinflammation, 13, 138, 10.1186/s12974-016-0605-8 · DOI
- Seppi, 2014, Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset, J. Neuroimmunol., 270, 56, 10.1016/j.jneuroim.2014.02.014 · DOI
- Rossi, 2014, Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis, J. Neuroinflammation, 11, 32, 10.1186/1742-2094-11-32 · DOI
- Furlan, 1999, Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study, J. Neurol. Neurosurg. Psychiatry, 67, 785, 10.1136/jnnp.67.6.785 · DOI · Paper page
- Heidary, 2014, The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients, J. Neurol. Sci., 343, 41, 10.1016/j.jns.2014.05.013 · DOI
- Peelen, 2015, Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis, Mol. Immunol., 63, 521, 10.1016/j.molimm.2014.10.008 · DOI
- Ko, 2014, GM-CSF-responsive monocyte-derived dendritic cells are pivotal in Th17 pathogenesis, J. Immunol., 192, 2202, 10.4049/jimmunol.1302040 · DOI · Paper page
- Dumas, 2014, The inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis, PLoS Pathog., 10, e1004150, 10.1371/journal.ppat.1004150 · DOI · Paper page
- Gao, 2016, Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells, J. Autoimmun., 69, 74, 10.1016/j.jaut.2016.03.002 · DOI
- Secor, 2000, Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis, J. Exp. Med., 191, 813, 10.1084/jem.191.5.813 · DOI · Paper page
- Sayed, 2010, Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?, J. Immunol., 184, 6891, 10.4049/jimmunol.1000126 · DOI · Paper page
- Christy, 2013, Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE, J. Autoimmun., 42, 50, 10.1016/j.jaut.2012.11.003 · DOI · Paper page
- Russi, 2016, Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity, J. Autoimmun., 73, 100, 10.1016/j.jaut.2016.06.015 · DOI · Paper page
- Russi, 2016, Mast cell inflammasome activity in the meninges regulates EAE disease severity, 10.1016/j.clim.2016.04.009 · DOI
- Suurmond, 2016, Expansion of Th17 cells by human mast cells is driven by inflammasome-independent IL-1β, J. Immunol., 197, 4473, 10.4049/jimmunol.1502640 · DOI
- McCandless, 2009, IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis, J. Immunol., 183, 613, 10.4049/jimmunol.0802258 · DOI · Paper page
- Mandolesi, 2013, Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis, J. Neurosci., 33, 12105, 10.1523/JNEUROSCI.5369-12.2013 · DOI · Paper page
- Murphy, 2010, Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis, Brain Behav. Immun., 24, 641, 10.1016/j.bbi.2010.01.014 · DOI · Paper page
- Martin, 2016, T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis, Nat. Immunol., 17, 583, 10.1038/ni.3389 · DOI · Paper page
- Guo, 2009, IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells, Proc. Natl. Acad. Sci. USA, 106, 13463, 10.1073/pnas.0906988106 · DOI · Paper page
- Chung, 2009, Critical regulation of early Th17 cell differentiation by interleukin-1 signaling, Immunity, 30, 576, 10.1016/j.immuni.2009.02.007 · DOI · Paper page
- Martínez-Llordella, 2013, CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response, J. Exp. Med., 210, 1603, 10.1084/jem.20122387 · DOI · Paper page
- Lin, 2014, Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation, Nat. Commun., 5, 3551, 10.1038/ncomms4551 · DOI · Paper page
- Fukaya, 2014, Loss of Sprouty4 in T cells ameliorates experimental autoimmune encephalomyelitis in mice by negatively regulating IL-1β receptor expression, Biochem. Biophys. Res. Commun., 447, 471, 10.1016/j.bbrc.2014.04.012 · DOI
- Ichiyama, 2016, The microRNA-183-96-182 cluster promotes T helper 17 cell pathogenicity by negatively regulating transcription factor Foxo1 expression, Immunity, 44, 1284, 10.1016/j.immuni.2016.05.015 · DOI · Paper page
- Robson, 2016, Generation and characterization of mice expressing a conditional allele of the interleukin-1 receptor type 1, PLoS One, 11, e0150068, 10.1371/journal.pone.0150068 · DOI
- Abdulaal, 2016, Characterization of a conditional interleukin-1 receptor 1 mouse mutant using the Cre/LoxP system, Eur. J. Immunol., 46, 912, 10.1002/eji.201546075 · DOI
- Mufazalov, 2016, Generation of a novel T cell specific interleukin-1 receptor type 1 conditional knock out mouse reveals intrinsic defects in survival, expansion and cytokine production of CD4 T cells, PLoS One, 11, e0161505, 10.1371/journal.pone.0161505 · DOI
- Rothhammer, 2015, Control of autoimmune CNS inflammation by astrocytes, Semin. Immunopathol., 37, 625, 10.1007/s00281-015-0515-3 · DOI · Paper page
- Liu, 2015, Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor-mediated effects in specific cell types, J. Neurosci., 35, 2860, 10.1523/JNEUROSCI.3199-14.2015 · DOI · Paper page
- Paré, 2017, Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: breaking the vicious cycle between IL-1beta and GM-CSF, Brain Behav. Immun., 62, 1, 10.1016/j.bbi.2016.07.146 · DOI
- Aubé, 2014, Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases, J. Immunol., 193, 2438, 10.4049/jimmunol.1400401 · DOI · Paper page
- Li, 2011, Endothelial IL-1R1 is a critical mediator of EAE pathogenesis, Brain Behav. Immun., 25, 160, 10.1016/j.bbi.2010.09.009 · DOI · Paper page
- Shirakawa, 1987, Expression of interleukin 1 receptors on human peripheral T cells, J. Immunol., 138, 4243, 10.4049/jimmunol.138.12.4243 · doi:10.4049/jimmunol.138.12.4243
- Lee, 2010, Regulating human Th17 cells via differential expression of IL-1 receptor, Blood, 115, 530, 10.1182/blood-2009-08-236521 · DOI · Paper page
- Sha, 2016, Activated IL-1RI signaling pathway induces Th17 cell differentiation via interferon regulatory factor 4 signaling in patients with relapsing-remitting multiple sclerosis, Front. Immunol., 7, 543, 10.3389/fimmu.2016.00543 · DOI
- Duhen, 2014, IL-1β promotes the differentiation of polyfunctional human CCR6+CXCR3+ Th1/17 cells that are specific for pathogenic and commensal microbes, J. Immunol., 193, 120, 10.4049/jimmunol.1302734 · DOI · Paper page
- Calderon, 2006, A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein, J. Neuroimmunol., 177, 27, 10.1016/j.jneuroim.2006.05.003 · DOI · Paper page
- Mayo, 2014, Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation, Nat. Med., 20, 1147, 10.1038/nm.3681 · DOI · Paper page
- Nicoletti, 1996, Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment, Cytokine, 8, 395, 10.1006/cyto.1996.0054 · DOI
- Perini, 2000, Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a, Eur. Cytokine Netw., 11, 81
- Comabella, 2008, Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis, J. Neurol., 255, 1136, 10.1007/s00415-008-0855-1 · doi:10.1007/s00415-008-0855-1
- Coclet-Ninin, 1997, Interferon-beta not only inhibits interleukin-1beta and tumor necrosis factor-alpha but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells, Eur. Cytokine Netw., 8, 345
- Jungo, 2001, IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact, Cytokine, 14, 272, 10.1006/cyto.2001.0884 · DOI
- Guarda, 2011, Type I interferon inhibits interleukin-1 production and inflammasome activation, Immunity, 34, 213, 10.1016/j.immuni.2011.02.006 · DOI · Paper page
- Burger, 2009, Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis, Proc. Natl. Acad. Sci. USA, 106, 4355, 10.1073/pnas.0812183106 · DOI · Paper page
- Caragnano, 2012, Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis, J. Neuroimmunol., 245, 93, 10.1016/j.jneuroim.2012.02.002 · DOI
- Carpintero, 2010, Glatiramer acetate triggers PI3Kδ/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes, Proc. Natl. Acad. Sci. USA, 107, 17692, 10.1073/pnas.1009443107 · DOI
- Carpintero, 2011, IFN-β and glatiramer acetate trigger different signaling pathways to regulate the IL-1 system in multiple sclerosis, Commun. Integr. Biol., 4, 112, 10.4161/cib.14205 · doi:10.4161/cib.14205
- Mellergård, 2010, Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid, Mult. Scler., 16, 208, 10.1177/1352458509355068 · DOI · Paper page
- Mellergård, 2012, Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis, PLoS One, 7, e44739, 10.1371/journal.pone.0044739 · DOI
- Furlan, 2007, HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice, Gene Ther., 14, 93, 10.1038/sj.gt.3302805 · DOI
- Warabi, 2007, Role of IL-1 and potential therapies in multiple sclerosis, Drug Discov. Today, 4, 19
- Dinarello, 2012, Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases, Nat. Rev. Drug Discov., 11, 633, 10.1038/nrd3800 · DOI · Paper page
- Schett, 2016, Interleukin-1 function and role in rheumatic disease, Nat. Rev. Rheumatol., 12, 14, 10.1038/nrrheum.2016.166 · DOI · Paper page
Cited by
McKenzie, B. A., Mamik, M. K., Saito, L. B., Boghozian, R., Monaco, M. C., Major, E. O., Lu, J.-Q., Branton, W. G., & Power, C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722041115 · Cited by 514
MAFG-driven astrocytes promote CNS inflammation
Wheeler, M. A., Clark, I. C., Tjon, E. C., Li, Z., Zandee, S. E. J., Couturier, C. P., Watson, B. R., Scalisi, G., Alkwai, S., Rothhammer, V., et al. (2020) · Nature · doi:10.1038/s41586-020-1999-0 · Cited by 501
Cano-Gamez, K., Soskic, B., Roumeliotis, T. I., So, E., Smyth, D. J., Baldrighi, M., Willé, D., Nakic, N., Esparza-Gordillo, J., Larminie, C. G. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15543-y · Cited by 274
Microglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
Buffolo, F., Petrosino, V., Albini, M., Moschetta, M., Carlini, F., Floss, T., Kerlero de Rosbo, N., Cesca, F., Rocchi, A., Uccelli, A., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03465-6 · Cited by 60
Metadata
- Authors
- Lin, C.-C., & Edelson, B. T.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-06
- Volume
- 198
- Issue
- 12
- Pages
- 4553-4560
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2624289631
- Cited by
- 157
- References
- 16
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.